The wearable technology sector is experiencing a genuine surge in popularity, but for investors, the path to profitability is shrouded in uncertainty.
Companies like Oura and Whoop are gearing up for initial public offerings, carrying valuations that are astonishingly high.
From sleep scores to heart rate metrics, a wide array of human physiological data can now be compiled into visual dashboards.
This leads investors to a seemingly logical conclusion: firms such as Oura and Whoop have perfected a model that turns personal health management into a sustainable, high-growth business. However, the historical trajectory of the consumer health hardware industry paints a very different picture.
The Oura smart ring, priced around $400, has captivated Wall Street and Silicon Valley, gaining endorsements from celebrities like Gwyneth Paltrow. The screenless Whoop band has locked in millions of fitness enthusiasts through its subscription model, with sports icons like LeBron James and Cristiano Ronaldo among its investors.
Both companies are expanding rapidly and plan to go public soon. Their recent valuations in private markets have reached a range of $100 to $110 billion, approximately ten times their revenue.
The sector's appeal is undeniable. New-generation wearables offer highly practical health insights, such as menstrual cycle prediction and detailed sleep analysis, fostering strong user loyalty. Data shows Oura has sold over 5.5 million smart rings, ranking it as a top wearable brand in the US by shipments in the first quarter of this year, trailing only Apple and Google. Whoop claims to have surpassed 2.5 million global paying members.
Nevertheless, investors must confront the cautionary tale left by Fitbit. A decade ago, this pioneer in fitness tracking went public, with its market capitalization nearing $100 billion at its peak—a figure comparable to the current valuations of Oura and Whoop. However, growth for single-function bands stalled as all-in-one smartwatches like the Apple Watch became ubiquitous. In 2021, Google acquired Fitbit for just $2.1 billion, less than two times its peak annual revenue.
Oura and Whoop do possess distinct advantages. They avoid the mass-market pedometer approach, focusing instead on premium hardware that integrates multiple biometric data points like heart rate variability and skin temperature to deliver actionable insights—early disease warnings, recovery scores, and training advice. They profit from high-margin subscription revenue, and their screenless products are positioned as companions to the Apple Watch or alternatives for users seeking to avoid another screen.
Yet, the premium hardware segment itself is fraught with historical challenges. Another brand once viewed by Wall Street as a high-growth software play—the exercise bike maker Peloton—maintained operating profit margins only in the high single digits even during its best years. The industry pattern is clear: companies ride a wave of consumer wellness enthusiasm, with the market valuing them solely on growth while ignoring sustainable profitability, until growth inevitably hits a ceiling.
An industry analyst noted that consumer hardware is notoriously volatile with thin margins. Direct-to-consumer health brands face extremely high customer acquisition costs, forcing them to spend heavily on advertising to offset churn from users who abandon tracking. Oura is currently running its largest-ever marketing campaign, with ads featured in major events like the NBA Finals. Such massive spending is necessary to sustain growth but continuously erodes profits.
Competition is also intense. Oura has frequently filed patent lawsuits to block competitors like Samsung and the Indian smart ring maker Ultrahuman. Yet, even if Oura defends its niche, the core metrics it monitors—like REM sleep duration and resting heart rate—can be captured by other affordable wearables, such as wrist-worn Fitbit devices, at no extra cost.
The most significant risk lies in the growth ceiling. While the smart ring category is one of the few wearables segments still expanding, the rate of user adoption may slow much faster than the optimistic expectations baked into a $110 billion valuation. Currently, Oura's core customers are high-earning, health-obsessed individuals in a "K-shaped" economy.
A more challenging question arises: once this premium market saturates, will the average consumer—who is already cutting back on spending at places like Target and on fast food—be willing to pay ongoing subscription fees merely for workout reminders?
Forecasts suggest global smart ring shipments will grow until 2027, but the US market is expected to enter a growth plateau by 2028. Analysts cite high pricing and a lack of disruptive core innovation as two key factors limiting the industry's expansion.
The only compelling optimistic narrative for the market is clinical integration: the transformation of wearables from wellness gadgets into professional monitoring tools incorporated into clinical workflows by doctors and insurers. However, this path is long and heavily regulated.
Once growth slows, valuation multiples contract rapidly. Consider Garmin: a consistently profitable company with almost zero debt and steady growth in its fitness device business. Its current valuation is only 5 to 6 times revenue, half the multiple of Oura and Whoop.
The widespread wellness trend does represent a profitable, perhaps enduring, niche in the modern economy: consumers scrutinizing cereal ingredients, exercising regularly, and buying organic produce.
But this remains a niche demand. LeBron James may invest heavily in his body and easily afford a Whoop subscription, but that does not mean the vast majority will follow suit.
Prospective investors considering these upcoming public offerings should carefully weigh the risks before jumping on the bandwagon.
Comments